D-1188-2022 Class I Terminated
FDA drug recall D-1188-2022 was initiated by Bryant Ranch Prepack, Inc. on Jun 17, 2022 and is designated Class I. Reason for recall: Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg… The recall status is terminated (terminated Apr 2, 2024).
Recall details
- Product Type
- Drugs
- Report Date
- Jul 20, 2022
- Initiation Date
- Jun 17, 2022
- Termination Date
- Apr 2, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Morphine Sulfate extended-Release Tablets, USP; 60 mg, 100-count bottles, Rx only, manufactured by: Ohm Laboratories Inc., NJ; Relabeled by: Bryant Ranch Prepack, Inc, CA, NDC 63629-1089-01
Reason for recall
Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.
Distribution pattern
Distributed to one wholesaler in AL for further distribution in the US.
Code information
Lot #: 179643, Exp. Date 08/31/2023.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1188-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026